deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02961673

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Sponsor: Huons Co., Ltd.

Conditions Glabellar Lines
Interventions Botox Inj HU-014 Inj
Updated 9 times since 2017 Last updated: Apr 10, 2018 Started: Sep 30, 2016 Primary completion: Feb 28, 2017 Completion: Mar 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Glabellar Lines, this trial is completed. The trial is conducted by Huons Co., Ltd. and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~May 2018 · 15 months · monthly snapshotRecruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Feb 2019 [monthly]

    Completed PHASE1_PHASE2

  2. May 2018 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    Status: Recruiting → Completed

  3. Feb 2017 — May 2018 [monthly]

    Recruiting PHASE1_PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Huons Co., Ltd.
Data source: Huons Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations